The latest biotech research report from RNCOS Industry
Research Solutions shows that there is a big chance for a 13% CAGR growth for Singapore's biotech market until 2012.
Considering that the most ground-breaking and highly advanced infrastructure can be found in Singapore, researchers see the horizon over this country of the Asia Pacific. The overall progress of Singapore is partly attributed by its government to the surging growth of its biotechnology industry.
The increase on the funding of the Singaporean government for research and development grew more than twice as how it had been from 2001 to 2005.
Apart from the enticing business atmosphere of Singapore, the essential infrastructure cannot be simply taken for granted. Further growth of its market is due to the strong favor of private sector companies interested on investing large shares for biotech.